Insights into Mechanism of Glucokinase Activation
暂无分享,去创建一个
M. Ammirati | J. Pfefferkorn | S. Greasley | Shenping Liu | X. Qiu | J. Knafels | Xi Song | Jeff Zhang
[1] Jing Chen,et al. Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. , 2012, Journal of medicinal chemistry.
[2] R. Vincentelli,et al. The active conformation of human glucokinase is not altered by allosteric activators. , 2011, Acta crystallographica. Section D, Biological crystallography.
[3] M. Ammirati,et al. Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus , 2011 .
[4] P. Njølstad,et al. Binding of ATP at the active site of human pancreatic glucokinase – nucleotide-induced conformational changes with possible implications for its kinetic cooperativity , 2011, The FEBS journal.
[5] Clemens Vonrhein,et al. Data processing and analysis with the autoPROC toolbox , 2011, Acta crystallographica. Section D, Biological crystallography.
[6] M. Larion,et al. Global fit analysis of glucose binding curves reveals a minimal model for kinetic cooperativity in human glucokinase. , 2010, Biochemistry.
[7] R. Brüschweiler,et al. Direct evidence of conformational heterogeneity in human pancreatic glucokinase from high-resolution nuclear magnetic resonance. , 2010, Biochemistry.
[8] Jill Trewhella,et al. Small‐angle scattering for structural biology—Expanding the frontier while avoiding the pitfalls , 2010, Protein science : a publication of the Protein Society.
[9] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[10] J. Zorn,et al. Turning enzymes ON with small molecules. , 2010, Nature chemical biology.
[11] A. Duttaroy,et al. Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes. , 2009, Journal of medicinal chemistry.
[12] G. Ferry,et al. Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states. , 2009, Biochemistry.
[13] Friedrich Förster,et al. Multiple conformations of E. coli Hsp90 in solution: insights into the conformational dynamics of Hsp90. , 2008, Structure.
[14] Greg L. Hura,et al. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. , 2011, Quarterly reviews of biophysics.
[15] John A. Tainer,et al. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution , 2007, Quarterly Reviews of Biophysics.
[16] Shaoxian Sun,et al. Biochemical Basis of Glucokinase Activation and the Regulation by Glucokinase Regulatory Protein in Naturally Occurring Mutations* , 2006, Journal of Biological Chemistry.
[17] A. Kadotani,et al. An Allosteric Activator of Glucokinase Impairs the Interaction of Glucokinase and Glucokinase Regulatory Protein and Regulates Glucose Metabolism* , 2006, Journal of Biological Chemistry.
[18] D. Nettleton,et al. Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis. , 2006, Biochemistry.
[19] J. Gromada,et al. A novel glucokinase activator modulates pancreatic islet and hepatocyte function. , 2005, Endocrinology.
[20] F. Matschinsky. Glucokinase, glucose homeostasis, and diabetes mellitus , 2005, Current diabetes reports.
[21] M. Magnuson,et al. Glucokinase as a Glucose Sensor: Past, Present and Future , 2004 .
[22] U. Kammlott,et al. Crystal Structure of Human Liver Glucokinase Bound to a Small Molecule Allosteric Activator , 2004 .
[23] H. Huopio,et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. , 2004, Diabetes.
[24] M. Magnuson,et al. Glucokinase and glycemic disease: from basics to novel therapeutics. , 2004 .
[25] Teruyuki Nishimura,et al. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. , 2004, Structure.
[26] M. Ravier,et al. Hierarchy of the β‐cell signals controlling insulin secretion , 2003, European journal of clinical investigation.
[27] A. Hattersley,et al. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. , 2003, Diabetes.
[28] J. Grippo,et al. Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy , 2003, Science.
[29] I. Weber,et al. Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia. , 1999, Diabetes.
[30] H. Fromm,et al. Regulation of hexokinase I: crystal structure of recombinant human brain hexokinase complexed with glucose and phosphate. , 1998, Journal of molecular biology.
[31] F M Matschinsky,et al. Familial hyperinsulinism caused by an activating glucokinase mutation. , 1998, The New England journal of medicine.
[32] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[33] G. Kleywegt,et al. Detecting folding motifs and similarities in protein structures. , 1997, Methods in enzymology.
[34] D. Svergun,et al. CRYSOL : a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates , 1995 .
[35] E. Van Schaftingen,et al. Short‐term control of glucokinase activity: role of a regulatory protein , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] M. Magnuson,et al. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. , 1994, The Journal of biological chemistry.
[37] A. Hattersley,et al. Linkage of type 2 diabetes to the glucokinase gene , 1992, The Lancet.
[38] M. Stoffel,et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.
[39] J. Beckmann,et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.
[40] K. Neet,et al. Demonstration of a slow conformational change in liver glucokinase by fluorescence spectroscopy. , 1990, The Journal of biological chemistry.
[41] P. Iynedjian,et al. Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. , 1988, The Journal of biological chemistry.
[42] D. I. Svergun,et al. Structure Analysis by Small-Angle X-Ray and Neutron Scattering , 1987 .
[43] T. Steitz,et al. Structural dynamics of yeast hexokinase during catalysis. , 1981, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[44] J. Ricard,et al. Enzyme memory. 2. Kinetics and thermodynamics of the slow conformation changes of wheat-germ hexokinase LI. , 1977, European Journal of Biochemistry.
[45] I. H. Segel. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .
[46] J. Ricard,et al. Regulatory Behavior of Monomeric Enzymes , 1974 .
[47] J. Ricard,et al. Regulatory behavior of monomeric enzymes. 1. The mnemonical enzyme concept. , 1974, European journal of biochemistry.
[48] K. Neet,et al. Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes. , 1972, The Journal of biological chemistry.